Publicacións (20) Publicacións de FRANCISCO JOSE JIMENO DEMUTH

2024

  1. Nursing diagnoses and hospital readmission of patients with respiratory diseases: Findings from a case–control study

    Nursing Open, Vol. 11, Núm. 5

2023

  1. Incidence and Determinants of Symptomatic and Asymptomatic SARS-CoV-2 Breakthrough Infections After Booster Dose in a Large European Multicentric Cohort of Health Workers-ORCHESTRA Project

    Journal of Epidemiology and Global Health, Vol. 13, Núm. 3, pp. 577-588

  2. Transcriptomic clustering of critically ill COVID-19 patients

    The European respiratory journal, Vol. 61, Núm. 1

2022

  1. Effects of IFIH1 rs1990760 variants on systemic inflammation and outcome in critically ill COVID-19 patients in an observational translational study

    eLife, Vol. 11

  2. SARS-CoV-2 Breakthrough Infections: Incidence and Risk Factors in a Large European Multicentric Cohort of Health Workers

    Vaccines, Vol. 10, Núm. 8

2021

  1. Variant-genetic and transcript-expression analysis showed a role for the chemokine-receptor CCR5 in COVID-19 severity

    International Immunopharmacology, Vol. 98

2019

  1. What can we learn from the public's understanding of drug information and safety? A population survey

    International Journal of Pharmacy Practice, Vol. 27, Núm. 1, pp. 96-104

2016

  1. Beers versus STOPP criteria in polyharmacy community-dwelling older patients

    Farmacia Hospitalaria, Vol. 40, Núm. 3, pp. 150-164

  2. Inappropriate prescriptions in polypharmacy involving elderly outpatients. Are the STOPP criteria useful?

    International Journal of Clinical Pharmacology and Therapeutics, Vol. 54, Núm. 3, pp. 172-176

  3. Optimización de la información sobre la medicación de personas polimedicadas en atención primaria

    Gaceta Sanitaria, Vol. 30, Núm. 1, pp. 69-72

2015

  1. Spontaneous reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with antiepileptic drugs

    European Review for Medical and Pharmacological Sciences, Vol. 19, Núm. 14, pp. 2732-2737

2014

  1. Letter to the editor: Reporting problems related to medications in Spain. The yonotifco (I report) project, an option for citizens

    International Journal of Clinical Pharmacology and Therapeutics

2013

  1. La notificación directa por los pacientes de reacciones adversas a medicamentos en España

    Farmacia Hospitalaria, Vol. 37, Núm. 1, pp. 65-71

  2. Trends in the pharmacological treatment of osteoporosis in Spain from 2000 to 2008

    Maturitas, Vol. 74, Núm. 1, pp. 74-78

2012

  1. Farmacovigilancia y errores de medicación

    Revista ROL de enfermería, Vol. 35, Núm. 3, pp. 8-18

2011

  1. Continuous reporting of new cases in Spain supports the relationship between Herbalife® products and liver injury

    Pharmacoepidemiology and Drug Safety, Vol. 20, Núm. 10, pp. 1080-1087

2010

  1. Intoxicación por opioides transdérmicos en un paciente con psoriasis generalizada

    Farmacia Hospitalaria

  2. Relevancia clínica de las notificaciones de reacciones adversas de atención primaria recibidas en el centro de farmacovigilancia de Asturias

    Semergen: revista española de medicina de familia, Núm. 2, pp. 63-68

2008

  1. Post-marketing safety of antineoplasic monoclonal antibodies: Rituximab and trastuzumab

    Pharmacoepidemiology and Drug Safety, Vol. 17, Núm. 7, pp. 714-721

  2. Seguridad de los agonistas beta-2-adrenérgicos inhalados: ¿qué aporta la notificación espontánea?

    Atencion Primaria